Yuki Nishida: Our research on MYC overexpression in TP53 mutant acute myeloid leukemia stem-like cells
Yuki Nishida, a Research Instructor at MD Anderson Cancer Center, shared a post by Edward Ayoub, TRIUMPH Postdoctoral Fellow at MD Anderson Cancer Center, on LinkedIn adding:
“Our research on MYC overexpression in TP53 mutant acute myeloid leukemia stem-like cells, and c-MYC targeting for TP53 mutant AML, was selected as Best of ASH!! Really appreciate for the selection, ASH2023!
Thank all lab members and collaborators and especially our mentor Dr. Michael Andreeff, for continuous support!
Thank you, Dr. Ayoub, for posting and your huge contribution to bioinformatics analyses!”
Quoting Edward Ayoub’s post:
“We’ve got selected for the Best of ASH for our oral abstract presented by Dr. Nishida! And got an abstract achievement award for our poster abstract presented by me! Congratulations Yuki Nishida and coauthors. Thank you American Society of Hematology.”
Sources: Yuki Nishida/LinkedIn and Edward Ayoub/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023